Pasqal appoints Florence Lao as CLO while management expands despite €4.9m H1 revenue
Pasqal, which develops neutral-atom quantum computers, appointed Florence Lao as chief legal officer (CLO) on October 1, 2026. Lao will serve as a strategic adviser to management and the board, overseeing global legal strategy including governance, securities-law compliance, intellectual property and regulatory matters.
✍️ Quantum Index Analysis
We explain the technical and business implications behind the announcement and the evaluation points that aren’t obvious from the numbers or headlines alone. Read our analysis ↓
Announcement summary
Lao’s remit covers corporate governance, securities-law compliance, commercial transactions, intellectual property, regulatory affairs, strategic growth initiatives and support for international operations. Pasqal says the move aims to shore up legal and governance foundations as it expands globally as a listed company.
Lao has roughly 20 years’ experience in international business law. Before joining Pasqal she was head of legal and company secretary at Deezer, and previously held senior legal roles at Adisseo and SMCP, where she was involved in SMCP’s 2017 listing on Euronext Paris. Early in her career she worked on M&A at Latham & Watkins and later served as deputy general counsel at Artémis.
Key points
- Pasqal appointed Florence Lao as chief legal officer on October 1, 2026.
- Lao will act as a strategic adviser to management and the board and will oversee global legal strategy.
- Her responsibilities span governance, securities-law compliance, commercial transactions, intellectual property, regulatory compliance, growth initiatives and support for international operations.
- Lao has held senior legal roles at Deezer, Adisseo and SMCP, and has experience supporting public listings.
Technical and business implications
This appointment can be seen as part of Pasqal’s effort to strengthen governance, securities-law compliance, intellectual property protection and international regulatory compliance as a listed company, building the management foundations to support business expansion. The announcement does not indicate any changes to quantum-computer development, product roadmaps, revenues or fundraising.
What to watch next
Going forward, attention will focus on whether concrete changes to governance arrangements, including the board and disclosure practices, are implemented. It will also be important to see how legal and regulatory structures for international expansion and strengthened IP management are actualized. In addition, watch for public disclosures of commercial or strategic growth initiatives that reflect Lao’s experience.
✍️ Quantum Index Analysis
Viewed on its own, this CLO appointment is not headline-grabbing. What is notable is that Pasqal has recently filled several C-suite roles in quick succession — CFO, CPO, CHRO and now CLO — indicating it is building out management functions. The company appears to be transitioning from a research-focused quantum startup to a listed technology company with capabilities in capital markets, products and organizational governance, including legal functions.
At the same time, given Pasqal’s current business scale, this management build-out represents a significant upfront investment.
Pasqal’s revenue for H1 2026 was €4.9m and its operating loss was €59.2m. A simple calculation shows the operating loss is roughly 12 times revenue. However, this includes €27.3m of share-based compensation and €10.2m of listing and business combination–related one-off costs. If those €37.5m are mechanically excluded, the remaining loss is about €21.7m, still roughly 4.4 times revenue. This is a simple arithmetic view of the cost structure, not Pasqal’s own adjusted-profit metric.
For the same H1 2026 period, a simple side-by-side of GAAP revenue and operating losses for public quantum companies looks like this:
| Company | H1 2026 revenue | Operating loss | Operating loss ÷ revenue | Notes |
|---|---|---|---|---|
| Pasqal | €4.9m | €59.2m | ≈12.1× | Includes €37.5m of share-based compensation and listing-related costs |
| IonQ | $144.7m | $608.8m | ≈4.2× | Acquisitions have broadened business beyond quantum computing |
| Infleqtion | $23.4m | $62.9m | ≈2.7× | Also operates in sensing and other areas beyond quantum computing |
| Rigetti | $9.5m | $54.0m | ≈5.7× | Primarily superconducting quantum computingsuperconducting quantum computingSuperconducting Quantum Computing / Superconducting Quantum Computing / Superconducting QubitAn implementation approach for quantum computers that operates superconducting circuits at ultra-low (cryogenic) temperatures and uses electrical quantum states as quantum bits (qubits).QI NoteCharacterized by fast gate operations, but performance is not determined by qubit count alone. Gate fidelity, coherence time, connectivity, and support for error correction should also be verified. |
| D-Wave | $5.9m | $108.0m | ≈18.2× | Revenue timing can vary significantly based on system sales recognition |
※Quantum Index calculated these figures by a simple arithmetic comparison of each company’s GAAP H1 2026 revenue and operating loss. Differences in business scope, accounting treatment, M&A, share-based compensation and one-off items mean this is not a precise ranking of company profitability.
The comparison shows that “being a quantum company and loss-making” alone does not capture each company’s situation. Pasqal’s headline operating-loss ratio is large, but H1 2026 was heavily affected by share-based compensation and one-off listing costs. Even excluding those items, organizational costs to support R&D and global expansion remain heavy relative to current revenue.
After listing, Pasqal secured approximately €313m in cash, so it is not in a position that requires immediate cost-cutting. The company may instead be intentionally assembling CFO, CPO, CHRO and CLO roles first to build an organization capable of supporting future revenue growth.
However, the ultimate judgment will not be the number of CxOs. Pasqal’s H1 2026 revenue stands at €4.9m while the company discloses a “booked and awarded business” pipeline of €70.4m. That figure includes not only customer contracts but also grants and tax credits.
What to watch is whether this pipeline converts into actual product and service revenue and whether the business grows to a scale that can absorb the advanced management infrastructure in product, sales, HR, finance and legal. More important than this CLO appointment alone is whether Pasqal can fill the “vessel” of being a listed company with the revenue needed to justify that structure.
NETWORKView the industry network surrounding Pasqal →Related articles
- Pasqal creates CPO and CHRO roles — strengthening management for device deployment and regional expansion
- Pasqal exits defense program PROQCIMA, refocusing on neutral-atom FTQC and commercial deployment
- Pasqal reports €4.9m H1 2026 revenue — where commercialization stands compared with other public quantum companies
